incremental cost effectiveness of preventing depression in at risk adolescents dickerson
DESCRIPTION
Mental HealthTRANSCRIPT
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Incremental cost-effectiveness of preventing depression in at-risk adolescents
John Dickerson, MSMay 1, 201218th Annual HMO Research Network Conference, Seattle, WA
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Frances L. Lynch, PhDJohn F. Dickerson, MS
Greg Clarke, PhDV Robin Weersing, PhDWilliam Beardslee, MD
Lynn DeBar, PhDTracey RG Gladstone, PhD
David Brent MDTami Mark, PhD
Giovanna Porta, MSJudy Garber, PhD
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Acknowledgements
Boston Rachel Ammirati Jim Cooney Kate Ginnis Mary Kate Little Ellen Murachver Shula Ponet Phyllis Rothberg Carol Tee
Nashville Mary Jo Coiro Beth Donaghey Laurel Duncan Liz Ezell Jocelyn Carter Wendi Marien Rachel SwanMatt Morris Brandyn Street Sarah Frankel Katie Gallerani Christian Webb Mi Wu
Pittsburgh Yuan Brustoloni Satish Iyengar Brian McKain Nadine Melhem Deena Palenchar Tim Pitts Jennifer Spendley Ebony West Nathan Wigham Jamie Zelazny
Portland Kristina Booker Alison Firemark Bobbi Jo Yarborough Stephanie Hertert Sue Leung Tracy O’Connor Kevin Rogers Jane Wallace
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Adolescent Depression
Point prevalence rates of 3-8% Average age of first onset = 15 years Lifetime prevalence rate of depression by end of
adolescence = 25% Relapse rate of 40% within 2 years; 75% within 5 years Symptoms of depression in adolescence are associated
with risk for full-blown disorder Most cases of recurrent adult depression have initial
onsets during adolescence
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Consequences of Adolescent Depression – Short Term
Difficulties in relationships Impaired school and work performance Increased risk for teen pregnancy Increased risk for substance abuse Reduced quality of life Higher rates of suicide attempts Higher health care costs Greater use of school and other social services
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Consequences of Adolescent Depression – Long Term
Poor functional outcomes in adulthood Reduced quality of life Higher rates of suicide attempts More psychiatric and medical hospitalizations Lower educational attainment More time out of work
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Risk Factors for Depression
Parental Depression Increases risk of youth depression by 40%
Sub-syndromal Depression symptoms Symptoms but not meeting diagnostic criteria Increases risk of youth depression by 30%
Previous Episodes of Depression
(Weisz et al. 2006; Birmaher & Brent 2007; TADS Team 2004; NICE 2008)
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Parental Depression
Strongest risk factor for depression in youth 4X greater risk of depression in children of depressed
parents Amongst adolescents seeking services for depression
most have parents with current mood disorders More internalizing and externalizing disorders,
cognitive delays, academic and social difficulties
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Treatment of Adolescent Depression
Evidence for pharmacotherapy and psychotherapy (interpersonal psychotherapy, cognitive-behavioral psychotherapy)
Only 25% of youth who meet depression criteria receive any type of treatment
50-60% of those treated in controlled research studies show improvement
Current clinical practice fails to alleviate the majority of the disease burden associated with depression
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Prevention and Mental Health
Clinical resources focused on current crises Researchers and clinicians trained in pathology-
based models Insurance and health care systems designed to
provide treatment of disease, prevention is typically less well funded
Most insurance does not currently cover prevention services for mental health
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Studies evaluating prevention interventions
Multiple RCT have demonstrated that it is possible to prevent depression episodes using psychotherapeutic interventions including CB approaches
In particular, two studies have demonstrated that a CB Prevention intervention can reduce the risk of depression episodes in youth of depressed parents (Clarke et al. 2001; Lynch et al. 2005; Garber et al. 2010)
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Prevention of Depression (POD) Study Specific Aims
To test the efficacy of a cognitive-behavioral (CB) program for preventing depression in at-risk adolescents, across 4 sites
To explore possible moderators To examine cost-effectiveness of program
compared to TAU
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Inclusion Criteria
At least one biological parent had a current and/or past depressive episode
Adolescents (13-17 years old) had Current subsyndromal symptoms of depression [CES-D > 20] A history of a diagnosed depressive disorder Or both
Both a selective and indicated sample
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Exclusion Criteria
Neither parent nor the teen could be bipolar or schizophrenic
Teens could not currently meet criteria for MDD or dysthymia currently be taking any anti-depressant medication have received cognitive-behavioral therapy
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Study Design
RCT 4 sites (Nashville, TN; Boston, MA;
Pittsburgh PA; Portland OR) Adolescents aged 13-17 years At-risk for depression 316 youth participated in study
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
POD Prevention Program
• Cognitive therapy approach
• Groups ranged in size from 3 to 10
• Mixed gender, expected 60-80% female
• 8 weekly Acute sessions, 90 minute per session
• 6 monthly Continuation sessions, also 90 min’s
• Parent group: weeks 1 and 8 (variable attendance)
• Led by Master’s level therapists
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Methods
Participants assessed at baseline, 3, and 9 months blind to intervention status
Randomized to either CBP or UC All participants could initiate or continue any
health care services, non-health services (e.g., school, social services)
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Clinical Outcome Measures
Schedule for Affective Disorders and Schizophrenia for School- Age Children (KSADS) Present and Lifetime Version (Kaufman et al. 1997)
Clinical Global Impression Scale (CGI) - Improvement (Guy 1976)
Child Depression Rating Scale (CDRS) –Revised (Poznanski et al. 1994; Brent et al. 2008).
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Clinical Effects for the CEA
Depression Free Days (DFD) Quality-adjusted Life Years (QALY) Used clinical data at each assessment Use linear interpolation between clinical
time points Summed over 9 months
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Cost Data
Comprehensive costs of interventions, usual care across service sectors, parent time costs
Collected concurrent with trial Sources of data
Interviews with study personnel Study activity and financial records Child and Adolescent Services Assessment (CASA)
Parent and youth report
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Types of Cost Included
• Interventions – CBP– Including training and supervision
• Usual Care health care General medical and mental health specialty
• Comprehensive services outside Health Including school, social services, juvenile justice
• Family costs Time, travel
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Valuation of resources
Study financial records• Estimated cost of Usual Care services
• Unit costs from large databases including MEPS, Marketscan Claims Databases, Previous Studies
(Lynch et al. 2005; Lynch et al. 2011; Domino et al. 2008)
• Parent and participant reported costs for outside health and other costs
• Estimated parent time costs using human capital approach
• All resources in 2009 $
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Statistical Analyses
Analyses were intention-to-treat basis
Hypotheses tests from based on group variable in OLS regression models
Bootstrapping with a single model with 1000 replications (BCa; Thompson et al. 2000; O’Brien & Briggs 2002; O’Brien et al. 1994).
Net benefit regression framework to estimate Cost Effectiveness Acceptability Curve (CEAC) Examine differential CE for subgroups indicated by primary clinical analyses (Hoch et al. 2005)
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Analyses
Main All randomized youth
Sensitivity Alternative QALY weights Removal of outliers
Sub-group analyses Based on clinical moderation analyses
Youth whose parents were actively depressed at baseline
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Missing Data
Complete clinical outcome and health services data on 87% of participants
Multiple imputation with chained equations (Royston 2004; Royston 2005) using STATA
Assumed missing at random Included all non-missing values at all time points and
baseline demographics in the models Created five imputation datasets (Little & Rubin 2002)
Table 1 – Sample Description
CBP TAU p
Adolescents (N=316) n=159 n=157
Age 14.8 (1.5) 14.8 (1.3) .66
Female 93 (58.5%) 92 (58.6%) .98
Caucasian 129 (82.7%) 125 (80.6%) .64
Latino/Hispanic 10 (6.3%) 11 (7.1%) .78
CES-D (entry qualifying score) 18.5 (9.1) 18.8 (9.6) .83
Children’s Depression Rating Scale - Revised 28.6 (8.0) 29.1 (8.5) .52
Household Income 81 (52.3%) 96 (63.6%) .045
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Incremental Differences in Clinical Outcomes at 9 months
CBP group had:
13 more DFDs (p=.008)0.022 more QALYs (p=.008)DFD increased over time for both groups
Table 3. Service Use thru 9 months
% with any use Mean use (SD)
CBP TAU CBP TAU
Inpatient Mental Health Days 1.9 1.3 33.3 (46.5) 11.0 (9.9)
Inpatient Alcohol or Drug Days 1.3 0 24.0 (28.3)
Counseling or Medication Visits 29.6 27.4 11.3 (17.3) 9.1 (14.3)
Day Hospital Days 0.6 0 106 (--)
Alcohol or Drug Treatment Visits 1.3 0.6 8.5 (6.4) 33.0 (--)
Crisis Services 2.5 0.6 24.0 (34.5) 2.0 (--)
Medical doctor visits 6.3 11.5 2.1 (1.5) 1.8 (1.1)
Emergency Room Visits 1.9 1.3 1 (--) 2.5 (2.1)
Days of Antidepressant Medication
5.7 5.1
110.9 (78.7) 126.0 (86.5)
Days of Stimulant Medication3.1 1.9
105.6 (74.2) 61.0 (30.0)
Days of Other Psych Medication 0.0 1.3 73.0 (70.4) 153.0 (--)
ANY School Services 20.1 22.9 29.1 (61.1) 44.9 (105.2)
Juvenile correction contact 1.3 3.2 10.0 (2.8) 5.2 (7.3)
Table 4. Cost (2009 USD) thru 9 months
CBP TAU CBP TAU
Non-Protocol Costs% with Any Cost/Mean Cost (SD) 52.1 50.3 882 (3,285) 740 (2,021)
Family Costs 38.2 36.9 55 (170) 109 (470)
Intervention Costs
CBP Program Costs 277 (108)
Intervention Family costs 314 (200)
Total Intervention Costs 591 (286)
TOTAL COST 1,579 (4,073) 802 (2,126)
Table 5: Adjusted cost effectiveness ratios
*. bias corrected; **. CBP never preferred for this group.
ICER (95% CI)*
DFD QALY
Full Sample (n=316) 59 (11 -263)
35,434(6,350 – 157,594)
Conservative QALY weight [70%] NA 47,250(8,706 – 210,125)
Excluding cost outlier (n=315) 34 (2 – 125)
20,417(1,193 – 75,188)
Excluding patients with ANY inpatient utilization (n=308)
20(-1– 76)
12,267(-751 –45,581)
Outpatient costs only (n=316) 44(7 – 192)
26,618(4,063 – 115,461)
Parental depression** Dominated Dominated
No parental depression 14(-7 – 42)
8,683 (-4,157–25,156)
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Figure 1. Cost-effectiveness Planes Base Case
Higher cost, worse outcome
Lower cost, worse outcome
Higher cost, better outcome
Lower cost, better outcome
-$2
,00
0-$
1,0
00
$0
$1
,00
0$
2,0
00
Incr
em
enta
l Tota
l Cost
-40 -30 -20 -10 0 10 20 30 40
Incremental Change in CDRS-DFD1000 replications; adjusted for age, baseline costs, race, household income, and gender differences
CDRS-DFDs -- through month 8
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Figure 2. Cost-effectiveness acceptability curve base case0
%2
5%
50
%7
5%
10
0%
Pro
bab
ility
Tre
atm
ent is
Cost
-Effect
ive
$0 $50,000 $100,000 $150,000 $200,000 $300,000 $400,000 $500,000
Willingness to Pay
QALY (CDRS-DFD-based) at Month 8
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Figure 3. Cost-effectiveness planes by subgroup
Higher cost, worse outcome
Lower cost, worse outcome
Higher cost, better outcome
Lower cost, better outcome
=$4,
000
-$2,
000
-$1,
000
$0$1
,000
$2,0
00$4
,000
Incr
emen
tal T
otal
Cos
t
-40 -30 -20 -10 0 10 20 30 40
Incremental Change in CDRS-DFD1000 replications; adjusted for age, baseline costs, race, household income, and gender differences
No Parental Depression at Baseline
Higher cost, worse outcome
Lower cost, worse outcome
Higher cost, better outcome
Lower cost, better outcome
=$4,
000
-$2,
000
-$1,
000
$0$1
,000
$2,0
00$4
,000
Incr
emen
tal T
otal
Cos
t
-40 -30 -20 -10 0 10 20 30 40
Incremental Change in CDRS-DFD1000 replications; adjusted for age, baseline costs, race, household income, and gender differences
Parental Depression at Baseline
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Figure 4. Cost-effectiveness acceptability curves by subgroup0%
25%
50%
75%
100%
Prob
abili
ty T
reat
men
t is
Cos
t-Effe
ctiv
e
$0 $50,000 $100,000 $150,000 $200,000 $300,000 $400,000 $500,000
Willingness to Pay
No Parental Depression at Baseline
0%25
%50
%75
%10
0%Pr
obab
ility
Tre
atm
ent i
s C
ost-E
ffect
ive
$0 $50,000 $100,000 $150,000 $200,000 $300,000 $400,000 $500,000
Willingness to Pay
Parental Depression at Baseline
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Preliminary Conclusions
CBP increased DFD and QALYs CBP significantly more expensive CBP is very likely to be cost-effective compared to
many medical services currently covered by most insurance programs
CBP highly cost-effective for youth whose parent’s depression was in REMISSION at baseline
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Limitations
Did not include productivity costs for youth Adult literature suggests productivity is the largest cost of depression Suggests substantial lost time from school
Did not include all family costs Included typical parent time costs Did NOT include caregiving time, coordination, other
Methods for calculating QALYs Followed standard methods, but did not directly measure utility weights No utility weights in youth available – used adult weights Weights do not account for comorbidity
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Future Directions
Replication over longer period of time Clinical outcomes and costs may change over time Data are collected through 32 months
Need better information on sub-groups Larger sample could help to understand moderation of clinical and cost
outcomes May need to adapt interventions for some risk groups
Co-treatment of parent and youth, sequential treatment of parent and youth
Need for Preference Based HRQL in youth Evidence that depression negatively affects HRQL in youth No preference based QALY weights for youth